BrandWikiReturn

BGI Group

BGI Group, formerly Beijing Genomics Institute, is a Chinese genomics company with headquarters in Yantian, Shenzhen. The company was originally formed in 1999 as a genetics research center to participate in the Human Genome Project.[3][4] It also sequences the genomes of other animals, plants and microorganisms.[5]

BGI has transformed from a small research institute, notable for decoding the DNA of pandas and rice plants, into a diversified company active in animal cloning, health testing, and contract research.[6][7][8] BGI's earlier research was continued by the Beijing Institute of Genomics, Chinese Academy of Sciences.[9] BGI Research, the group's nonprofit division, works with the Institute of Genomics and operates the China National GeneBank under a contract with the Chinese government.[10][11] BGI Genomics, a subsidiary, was listed on the Shenzhen Stock Exchange in 2017. The company is supported by several China Government Guidance Funds and Chinese state-owned enterprises.[12]

Starting in 2021, details came to light about multiple controversies involving the BGI Group.[13] These controversies include alleged collaboration with the People's Liberation Army (PLA) and use of genetic data from prenatal tests.[14] BGI denied that it shares prenatal genetics data with the PLA.[15]

History

Beijing Genomics Institute

Wang Jian, Yu Jun, Yang Huanming and Liu Siqi created BGI, originally named Beijing Genomics Institute, in September 1999,[16] in Beijing, China as a non-governmental independent research institute in order to participate in the Human Genome Project as China's representative.[17] After the project was completed, funding dried up, after which BGI moved to Hangzhou in exchange for funding from the Hangzhou Municipal Government. In 2002, BGI sequenced the rice genome, which was a cover story in the journal Science. In 2003, BGI decoded the SARS virus genome and created a kit for detection of the virus.[18] In 2003, the Chinese Academy of Sciences founded the Beijing Institute of Genomics in cooperation with BGI, with Yang Huanming as its first director. BGI Hangzhou and the Zhejiang University also founded a new research institute, the James D. Watson Institute of Genome Sciences, Zhejiang University.[19]

Spin-off from the Beijing Genomics Institute

In 2007, BGI broke away from the Chinese Academy of Sciences, became a private company, and relocated to Shenzhen.[20][10] Yu Jun left BGI at this time purportedly selling his stake to the other 3 founders for a nominal sum.[5] In 2008, BGI published the first human genome of an Asian individual.[21]

In 2010, BGI bought 128 Illumina HiSeq 2000 gene-sequencing machines,[3][22] which was backed by US$1.5 billion in "collaborative funds" over the next 10 years from the state lender China Development Bank.[5][23][24] By the end of the year, they reportedly had a budget of $30 million. In 2010, BGI Americas was established with its main office in Cambridge, Massachusetts, US, and BGI Europe was established in Copenhagen, Denmark.[25][26] By 2018, BGI opened offices and laboratories in Seattle and San Jose in US,[3] and London in the UK, as well were founded BGI Asia Pacific with offices in Hong Kong, Kobe (Japan), Bangkok (Thailand), Laos, Singapore, Brisbane (Australia) and many others.[27][28]

In 2011, BGI reported it employed 4,000 scientists and technicians,[29] and had a $192 million in revenue.[5] BGI did the genome sequencing for the deadly 2011 Germany E. coli O104:H4 outbreak in three days and released it under an open license.[30] Since 2012, it has started to commercialize its services, having investments from China Life Insurance Company, CITIC Group's Goldstone Investment, Jack Ma's Yunfeng Capital, and SoftBank China Capital.[31] That year they also launched their own scientific journal, GigaScience,[32] partnering with BioMed Central to publish data-heavy life science papers.[33] A new partnership was subsequently formed between the GigaScience Press department of BGI and Oxford University Press and since 2017 GigaScience has been co-published with the Oxford University Press.[34][35] In September 2025 BGI removed the international Editorial, Software and GigaDB teams, and BGI Chief Scientist Xu Xun appointed himself as publisher and editor-in-chief.[36] In November 2025 the majority of the Editorial Board resigned citing concerns the lack of any consultation and concerns about how these changes may affect the journal's long-standing commitment to publishing rigorously reviewed, reproducible research.[37]

In 2013, BGI bought Complete Genomics of Mountain View, California, a major supplier of DNA sequencing technology, for US$118 million, after gaining approval from the Committee on Foreign Investment in the United States.[5][30][38] Complete Genomics is a US-based subsidiary of MGI, MGI was a subsidiary of BGI before it was spun out and listed on the Shanghai Stock Exchange in 2022.[39]

In 2015, BGI signed a collaboration with the Zhongshan Hospital' Center for Clinical Precision Medicine in Shanghai, opened in May 2015 with a budget of ¥100 million. They are reportedly being involved as a sequencing institution in China's US$9.2-billion research project for medical care which will last for 15 years.[3][40] In May 2017, was announced formation of West Coast Innovation Center, co-located in Seattle and San Jose, on the first location planned to work on precision medicine and feature collaborations with University of Washington, the Allen Institute for Brain Science, the Bill & Melinda Gates Foundation, and Washington State University, while on the second's already existing laboratory with 100 employees to develop the next-generation sequencing technologies.[3] In May 2018, reached an agreement with Mount Sinai Hospital (Toronto), Canada, for first installation of BGISEQ platforms in North America.[41]

BGI Genomics, a subsidiary of the group[42] made an initial public offering in July 2017 at Shenzhen Stock Exchange.[10] In 2018, the BGI was reportedly 85.3% owned by Wang Jian, and the group owns 42.4% of its main unit BGI Genomics.[43]

In 2019, it was reported that a BGI subsidiary, Forensic Genomics International, had created a WeChat-enabled database of genetic profiles of people across the country.[44][45][46][47][48] In July 2020, it was reported that BGI returned a Paycheck Protection Program loan following media scrutiny.[49]

In 2021, state-owned enterprises of State Development and Investment Corporation and China Merchants Group took ownership stakes in BGI Genomics.[50]

GigaScience Press

GigaScience Press is the Hong Kong-based publishing arm of BGI Group, currently publishing the open access journals GigaScience (co-published with Oxford University Press), GigaByte, and the GigaDB data publishing platform.[51] Focusing on open science, its journals have combined data publishing, transparent open peer review alongside carrying out other experiments in publishing more reproducible papers.

Their journals have won the Association of American Publishers' PROSE Award for Innovation in journal publishing in 2018,[52] and the ALPSP Award for Innovation in Publishing in 2022[53] for these efforts. In 2025, GigaScience Press won one of the first Crossref Excellence in Metadata awards[54] based on the quality of their metadata.[54]

GigaScience Press

GigaScience Press is the Hong Kong-based publishing arm of BGI Group, currently publishing the open access journals GigaScience (co-published with Oxford University Press), GigaByte, and the GigaDB data publishing platform.[51] Focusing on open science, its journals have combined data publishing, transparent open peer review alongside carrying out other experiments in publishing more reproducible papers.

Their journals have won the Association of American Publishers' PROSE Award for Innovation in journal publishing in 2018,[52] and the ALPSP Award for Innovation in Publishing in 2022[53] for these efforts. In 2025, GigaScience Press won one of the first Crossref Excellence in Metadata awards[54] based on the quality of their metadata.[54]

U.S. sanctions

In July 2020, the United States Department of Commerce's Bureau of Industry and Security placed two BGI subsidiaries on its Entity List for assisting in alleged human rights abuses due to its genetic analysis work in Xinjiang.[55][56] In March 2023, the United States Department of Commerce added BGI Research and BGI Tech Solutions (Hongkong) to the Entity List over allegations of surveillance and repression of ethnic minorities.[57]

BGI subsequently hired lobbyists at Steptoe & Johnson to soften language in the National Defense Authorization Act for Fiscal Year 2024 that would prohibit government funding of BGI and its subsidiaries.[58]

As of 2024, BGI is identified in a list by the United States Department of Defense as a Chinese military company operating in the U.S.[59] In April 2024, the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party asked the Department of Defense for an explanation for why BGI subsidiaries Innomics and STOmics were not included in the same list.[60]

Research

E. coli

In 2011, BGI sequenced the genome of E. coli bacteria causing an epidemic in Europe to identify genes that lead to resistance to antibiotics.[61]

COVID-19

In January 2020, BGI Genomics announced its real-time fluorescent RT-PCR kit that helps in identification of SARS-CoV-2 virus that causes COVID-19. This was subsequently verified and authorized for use in 14 countries and regions, including emergency use listing by the World Health Organization.[62] BGI Genomics reported that by April 2021 the RT-PCR kits had been distributed to more than 180 countries and regions. BGI also developed biosafety level 2 high-throughput nucleic acid detection laboratories, named Huo-Yan laboratories.[35][63]

In the first half of 2020, BGI Group offered to help the state of California set up COVID-19 testing labs at cost. The government of California rejected the offer due to geopolitical concerns, but Santa Clara County did buy COVID-19 test kits and equipment from BGI.[64]

On 25 August 2020, Reuters reported that about 3,700 people in Sweden were told in error that they had the coronavirus due to a fault in a COVID-19 testing kit from BGI Genomics.[65] Despite being the 5th test to be given WHO Emergency Use Listing,[66] and getting top marks in sensitivity tests in a Dutch study independently validating commercially available tests.[67] BGI Genomics defended the product, blaming differences in thresholds used between labs looking at very low levels of the virus.[68]

Bioinformatics technology

The annual budget for the computer center was US$9 million.[69] In the same year, BGI's computational biologists developed the first successful algorithm, based on graph theory, for aligning billions of 25 to 75-base pair strings produced by next-generation sequencers, specifically Illumina's Genome Analyzer, during de novo sequencing.[70]

SOAPdenovo is part of "Short Oligonucleotide Analysis Package" (SOAP), a suite of tools developed by BGI for de novo assembly of human-sized genomes, alignment, SNP detection, resequencing, indel finding, and structural variation analysis. Built for the Illumina sequencers' short reads, SOAPdenovo has been used to assemble multiple human genomes[71][72][73] (identifying an eight kilobase insertion not detected by mapping to the human reference genome[74]) and animals, like the giant panda.[75]

Up until 2015, BGI had released BGISEQ-100, based on Thermo Fisher Scientific's Ion Torrent device, and BGISEQ-1000, for both of which received an approval from the CFDA for a NIFTY (Non-invasive Fetal Trisomy Test) prenatal test.[76] In October 2015, BGI launched BGISEQ-500,[77] a larger desktop sequencing system. It reportedly received more than 500 orders for the system and run over 112,000 tests until late 2016.[76] The China National GeneBank, opened by BGI and Chinese Government in September 2016,[78] has 150 instruments of the system.[76] The BGISEQ-500 was developed as a sequencing platform capable of competing with Illumina's platforms.[79] In November 2016, BGI launched BGISEQ-50, a miniature version of desktop sequencer.[80] In 2017, BGI began offering WGS for $600.[3] In September 2022, MGI launched DNBSeq-G99, a new ultra-high-speed, mid-to-low throughput sequencer.[81]

In 2021, BGI developed Stereo-seq, its genome wide Spatial transcriptomics technology and released the first research findings from a consortium of scientific users of the technology in 2022.[82][83] In 2022, BGI-Research and University of Chinese Academy of Sciences together with scientists globally, used sequencing technologies to undertake single cell sequencing to expand the understanding of early human embryonic development, to complete the first whole-body cell atlas of a non-human primate, to complete the world's first body-wide single cell transcriptome atlas of pigs, and to study the brains of ants to explain for the first time how the social division of labor within ant colonies is determined by functional specialization of their brains at cellular levels.[84][85]

Agriculture and biodiversity

In 2002, BGI published the genome of the indica variety of rice.[86] In 2014, BGI also collaborated on a project to re-sequence 3,000 rice genomes from 89 countries.[87]

BGI is a member of the international Earth BioGenome Project which aims to sequence the DNA of all known eukaryotic species on Earth.[88] BGI has contributed to the 10KP Genome Sequencing Project, an affiliated project to sequence over 10,000 plant genomes.[89]

Animal Kingdom

In 2004, BGI was a Member of the International Chicken Genome Consortium that published the genome of the chicken.[90] In 2009, BGI published the genome of the Giant Panda.[91]

In 2014, BGI and scientists from 20 countries worked together to complete the genome-wide sequencing of 48 bird species.[92] In 2020, BGI contributed to the completion of whole genome sequencing of 363 genomes from 92.4% of bird families.[93]

In 2022, BGI led research that published the world's first spatiotemporal map of axolotl brain regeneration.[94] During the same year, a study carried out by BGI, Northeast Forestry University, and other institutions revealed the genomics consequences of inbreeding in the South China tiger by examining its chromosome-scale genomes and comparing it with the Amur tiger.[95]

In 2023, BGI and a scientific consortium jointly published a primate brain cell atlas.[96]

Legal disputes

In 2019, competitor Illumina, Inc. filed multiple patent infringement lawsuits against BGI.[97][98] In response, BGI has filed patent infringement lawsuits against Illumina alleging violations of federal antitrust and California unfair competition laws.[99] In May 2022 a US court ordered Illumina to pay US$333.8 million to BGI Group after finding that Illumina's DNA-sequencing systems infringed two of BGI's patents.[100] The ruling also stated Illumina infringed the patents willfully, and that three patents it had accused BGI's Complete Genomics subsidiary of infringing were invalid.[101] In July 2022 Illumina and MGI Tech Co. and Complete Genomics, settled US suits on DNA-sequencing technology, with Illumina agreeing to pay $325 million to settle all US litigation. As part of the settlement Illumina will receive a license to the BGI affiliates' patents, and both companies agreed to not sue each other for patent or antitrust violations in the United States for three years.[102]

In a September 2024 testimony before the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party, academic Anna B. Puglisi stated that she received legal threats from BGI Group for a report she wrote while serving Georgetown University's Center for Security and Emerging Technology.[103][104]

Collaboration with the People's Liberation Army

In January 2021, Reuters reported that BGI has worked with the People's Liberation Army (PLA) and affiliated institutions such as the National University of Defense Technology on efforts to enhance soldiers' strength and other projects.[105] In July 2021, Reuters reported that BGI developed a prenatal test, with the assistance of the People's Liberation Army, which is also used for genetic data collection.[106][14] In an interview with the South China Morning Post, a BGI representative denied the Reuters report.[15] The South China Morning Post stated that BGI published papers with the People's Liberation Army General Hospital and the Army Medical University, explaining in the article that in China "many top-notch hospitals are affiliated with the military."[15] BGI further stated "All NIPT data collected overseas are stored in BGI's laboratory in Hong Kong and are destroyed after five years, as stipulated by General Data Protection Regulation (GDPR)".[107] BGI also stated "BGI has never been asked to provide, nor has it provided data from its NIFTY tests to Chinese authorities for national security or national defense security purposes."[106]

In response to the Reuters report, a German privacy regulator launched a probe of a German company's use of BGI's prenatal genetic tests.[108] In August 2021, the UK announced a registration requirement with the Medicines and Healthcare products Regulatory Agency for BGI's prenatal tests.[109] Regulators in Australia, Estonia, Canada, and Poland also raised concerns as did the U.S. National Counterintelligence and Security Center.[110][111][112]

In November 2021, Reuters reported that a University of Copenhagen professor, Guojie Zhang, who was also employed by BGI was developing drugs for the PLA to assist soldiers with managing altitude sickness. BGI stated that the study "was not carried out for military purposes."[113] On 1 December 2021, the University of Copenhagen commented on the Reuters report.[114]

In October 2022, the United States Department of Defense added BGI Genomics Co, a listed subsidiary, to a list of "Chinese military companies" operating in the U.S.[115][116]

See also

  • Chinese National Human Genome Center
  • Wellcome Sanger Institute
  • Broad Institute

External links

References

  1. James Kon. MoH receives COVID-19 detection kits Borneo Bulletin, 18 March 2020, retrieved 7 February 2022^
  2. BGI Genomics Raises $81M in IPO Genetic Engineering & Biotechnology News, 17 July 2017, retrieved 2 December 2018^
  3. Megan Molteni. A Chinese Genome Giant Sets Its Sights on the Ultimate Sequencer Wired, 18 May 2017, retrieved 2 December 2018^
  4. Aaron Saenz. BGI – China's Genomics Center Has A Hand in Everything Singularity Hub, Singularity University, 11 November 2010, retrieved 2 December 2018^
  5. Shu-Ching Jean Chen. Genomic Dreams Coming True in China Forbes Asia, 2 September 2013, retrieved 27 October 2014^
  6. China's BGI says it can sequence a genome for just $100 MIT Technology Review, retrieved 2022-01-30^
  7. Ximiao He, Jun Wang. Plant Bioinformatics 2007, retrieved 2022-02-01^
  8. China cloning on an 'industrial scale' BBC News, 2014-01-14, retrieved 2022-01-29^
  9. David Cyranoski. Chinese bioscience: The sequence factory Nature, 2010^
  10. Matthew Campbell, Dong Lyu. China's Genetics Giant Wants to Tailor Medicine to Your DNA Bloomberg Businessweek, 13 November 2019, retrieved 2022-01-30^
  11. COVID opens new doors for China's gene giant mint, 2020-08-05, retrieved 2022-01-30^
  12. Anna Puglisi, Chryssa Rask. China, Biotechnology, and BGI Center for Security and Emerging Technology, May 2024, retrieved 2024-09-20^
  13. Anna Puglisi, Chryssa Rask. China, Biotechnology, and BGI Center for Security and Emerging Technology, May 2024, retrieved 2024-05-10^
  14. Kirsty Needham, Clare Baldwin. China's gene giant harvests data from millions of women Reuters, 7 July 2021, retrieved 10 July 2021^
  15. Iris Deng. BGI denies it shared genetic data of pregnant women with China's military and vows to continue overseas push South China Morning Post, 2021-07-12, retrieved 2021-07-14^
  16. Innovation with Chinese Characteristics: High-Tech Research in China Palgrave Macmillan UK, 2007^
  17. The dragon's DNA, 17 June 2010, The Economist.^
  18. E'de Qin, Xionglei He, Wei Tian, Yong Liu, Wei Li, Jie Wen, Jingqiang Wang, Baochang Fan. A Genome Sequence of Novel SARS-CoV Isolates: the Genotype, GD-Ins29, Leads to a Hypothesis of Viral Transmission in South China Genomics, Proteomics & Bioinformatics, 2003-05-01^
  19. Lawrence R. Sullivan, Nancy Y. Liu-Sullivan. Historical Dictionary of Science and Technology in Modern China Rowman & Littlefield, 2015-03-19, retrieved 2022-10-06^
  20. Kai Wang, Xiaobai Shen, Robin Williams. Sequencing BGI: the evolution of expertise and research organisation in the world's leading gene sequencing facility New Genetics and Society, 2021-07-03^
  21. Ye, Jia (2008) An Interview with a Leader in Genomics — Beijing Genomics Institute Asia Biotech. Retrieved 14 January 2013.^
  22. Kevin Davies, (27 September 2011) The Bedrock of BGI: Huanming Yang Bio-IT World. Retrieved 14 January 2014.^
  23. BGI to Receive $1.5B in 'Collaborative Funds' Over 10 Years from China Development Bank | In Sequence | Sequencing | GenomeWeb 12 January 2010, retrieved 29 March 2010^
  24. J. Fox, J. Kling. Chinese institute makes bold sequencing play Nature Biotechnology, 2010^
  25. BGI Expands Into Denmark with Plans for $10M Headquarters, Staff of 150 Genomeweb, 2010-05-19, retrieved 2022-09-20^
  26. BGI Opens Branches in US, Denmark; to Invest $10M in Copenhagen Site During First Year Genomeweb, 2010-05-25, retrieved 2022-09-20^
  27. BGI Asia Pacific BGI, retrieved 3 December 2018^
  28. Offices and Laboratories BGI, retrieved 3 December 2018^
  29. Lone Frank, High-Quality DNA, 24 April 2011, The Daily Beast^
  30. Michael Specter. The Gene Factory The New Yorker, 2013-12-30, retrieved 2022-10-23^
  31. Genome Giant Seeks $1 Billion for Equipment Unit for Potential IPO Caixin, 19 July 2018, retrieved 3 December 2018^
  32. Large and linked in scientific publishing the launch of big data journal GigaScience EurekAlert!, retrieved 2019-06-17^
  33. Andrew Pollack. DNA Sequencing Caught in Deluge of Data The New York Times, 2011-11-30, retrieved 2019-06-17^
  34. GigaScience. - NLM Catalog - NCBI www.ncbi.nlm.nih.gov, retrieved 2022-02-05^
  35. Julianna LeMieux, PhD. BGI's Coronavirus Response? Build a Lab in Wuhan GEN - Genetic Engineering and Biotechnology News, 2020-02-12, retrieved 2022-01-27^
  36. Open Bioinformatics Foundation. GigaScience: 15 years of great open science publishing & the end of an era? Open Bioinformatics Foundation, retrieved 2025-11-05^
  37. Avery Orrall. Dozens of board members resign from big-data journal after mass staff firings Retraction Watch, 2025-11-03, retrieved 2025-11-05^
  38. China's Biotechnology Development: The Role of US and Other Foreign Engagement United States-China Economic and Security Review Commission, 2019-02-14, retrieved 2022-10-23^
  39. Jamie Smyth, Demetri Sevastopulo. Chinese genetics company targets US despite political tensions Financial Times, 18 April 2023, retrieved 2023-04-18^
  40. David Cyranoski. China embraces precision medicine on a massive scale Nature, 6 January 2016, retrieved 2 December 2018^
  41. A Chinese company unveils a powerful new sequencer. But can it compete in the U.S.? Stat, 26 October 2018, retrieved 3 December 2018^
  42. Special Report: COVID opens new doors for China's gene giant Reuters, 2020-08-05, retrieved 2022-10-23^
  43. MGI raise $518M in Shanghai IPO, shares jump 14.71% on debut Bioworld, retrieved 2022-09-14^
  44. Yves Moreau. Crack down on genomic surveillance Nature, 2019-12-03^
  45. BGI officially enters Urumqi High-tech Zone www.uhdz.gov.cn, 2016-07-27, retrieved 2019-12-07^
  46. David Cyranoski. China expands DNA data grab in troubled western region Nature, 25 May 2017^
  47. Sui-Lee Wee, Paul Mozur. China Uses DNA to Map Faces, With Help From the West The New York Times, 2019-12-03, retrieved 2020-02-15^
  48. Bethany Allen-Ebrahimian, Zach Dorfman. Chinese coronavirus test maker agreed to build a Xinjiang gene bank Axios, 2020-06-03, retrieved 2020-06-03^
  49. Bethany Allen-Ebrahimian. Chinese biotech giant's U.S. subsidiary returns PPP loan after Axios story Axios, 2020-07-20, retrieved 2020-07-20^
  50. Kirsty Needham. Chinese state fund invests in gene firm BGI Reuters, 2021-02-22, retrieved 2022-10-23^
  51. Home Gigascience Press, retrieved 2025-07-24^
  52. 2018 Award Winners proseawards.com, retrieved 2025-07-24^
  53. Estelle awarded ALPSP Award for Contribution to Scholarly Publishing The Bookseller, retrieved 2025-07-24^
  54. Crossref announces inaugural Metadata Awards Research Information, 2025-05-07, retrieved 2025-07-24^
  55. Zachary Basu. U.S. blacklists Chinese companies tied to Xinjiang gene bank project Axios, July 20, 2020, retrieved July 20, 2020^
  56. Commerce Department Adds Eleven Chinese Entities Implicated in Human Rights Abuses in Xinjiang to the Entity List U.S. Department of Commerce, 2020-07-20, retrieved 2020-07-20^
  57. Alexandra Alper, David Shepardson. U.S. adds units of China's BGI, Inspur to trade blacklist Reuters, 2023-03-02, retrieved 2023-03-02^
  58. Caitlin Oprysko. Potential crackdown on foreign genomics firms sparks a lobbying fight Politico, 2023-11-29, retrieved 2023-12-08^
  59. Notice of Availability of Designation of Chinese Military Companies www.federalregister.gov, 2 April 2024, retrieved 2024-04-24^
  60. Bryant Harris. House panel questions Pentagon on Chinese biotech firms Federal Times, 2024-04-01, retrieved 2024-06-02^
  61. China helps unravel new E.coli for embattled Europe Reuters, 3 June 2011, retrieved 3 June 2011^
  62. Covid-19: BGI launches RT-PCR SARS-CoV-2 test for clinical use in US Medical Device Network, 2020-03-19, retrieved 2022-01-31^
  63. Peter Burdin. Africa's world-leading pandemic response New African, 2021-11-16, retrieved 2022-01-27^
  64. California rejected Chinese company's push to help with coronavirus testing. Was that the right move? Washington Post, retrieved 10 March 2023^
  65. Simon Johnson. Thousands of Swedes got false positive COVID-19 result due to test kit fault Reuters, 25 August 2020, retrieved 27 August 2020^
  66. World Health Organisation. WHO Emergency Use Listing for In vitro diagnostics (IVDs) Detecting SARS-CoV-2 retrieved 2020-11-01^
  67. Chinese Covid-19 test kit outstrips alternatives in Dutch study South China Morning Post, 2020-05-20, retrieved 2020-11-01^
  68. China's BGI defends COVID-19 test kit after Swedish criticism Reuters, 2020-08-26, retrieved 2020-11-01^
  69. G. A. Petsko. Rising in the East Genome Biology, 2010^
  70. To Start Building 'Human Pan-Genome,' BGI De Novo Assembles Two Genomes from Illumina Data | In Sequence | Sequencing | GenomeWeb 8 December 2009, retrieved 29 March 2010^
  71. R. Li, H. Zhu, J. Ruan, W. Qian, X. Fang, Z. Shi, Y. Li, S. Li. De novo assembly of human genomes with massively parallel short read sequencing Genome Research, 2009^
  72. M. Rasmussen, Y. Li, S. Lindgreen, J. S. Pedersen, A. Albrechtsen, I. Moltke, M. Metspalu, E. Metspalu. Ancient human genome sequence of an extinct Palaeo-Eskimo Nature, 2010^
  73. J. Wang, W. Wang, R. Li, Y. Li, G. Tian, L. Goodman, W. Fan, J. Zhang. The diploid genome sequence of an Asian individual Nature, 2008^
  74. BGI Uses New Short-Read Algorithm to Assemble Panda Genome as Proof of Concept for Human Genome | BioInform | Informatics | GenomeWeb 12 June 2009, retrieved 28 March 2010^
  75. R. Li, W. Fan, G. Tian, H. Zhu, L. He, J. Cai, Q. Huang, Q. Cai. The sequence and de novo assembly of the giant panda genome Nature, 2009^
  76. BGI Launches New Desktop Sequencer in China, Registers Larger Version With CFDA 360Dx, GenomeWeb, 11 November 2016, retrieved 2 December 2018^
  77. Julia Karow. BGI Launches Desktop Sequencer in China; Plans to Register Platform With CFDA GenomeWeb, 26 October 2015, retrieved 2 December 2018^
  78. Monica Heger. China National GeneBank Opens With Investments From BGI, Government GenomeWeb, 21 September 2016, retrieved 2 December 2018^
  79. BGI Retools Complete Genomics Technology for Its New High-Throughput Benchtop Sequencer Bio-ITWorld, Cambridge Healthtech Institute, 28 October 2015, retrieved 2 December 2018^
  80. Monica Heger. BGI Launches New Sequencer as Customers Report Data From Earlier Instruments GenomeWeb, 26 October 2018, retrieved 2 December 2018^
  81. MGI Tech Launches New Ultra-High-Speed, Mid-to-Low Throughput Sequencer Pubs - GenomeWeb, 27 September 2022, retrieved 2022-09-27^
  82. Vivien Marx. Method of the Year: spatially resolved transcriptomics Nature, 2021-01-06^
  83. SpatioTemporal Omics consortium: Cell Press www.cell.com, retrieved 2022-11-09^
  84. Md. Abdul Mazid, Carl Ward, Zhiwei Luo, Chuanyu Liu, Yunpan Li, Yiwei Lai, Liang Wu, Jinxiu Li. Rolling back human pluripotent stem cells to an eight-cell embryo-like stage Nature, 12 May 2022, retrieved 9 November 2022^
  85. Qiye Li, Mingyue Wang, Pei Zhang, Yang Liu, Qunfei Guo, Yuanzhen Zhu, Tinggang Wen, Xueqin Dai. A single-cell transcriptomic atlas tracking the neural basis of division of labour in an ant superorganism Nature Ecology & Evolution, 16 June 2022^
  86. Jun Yu, Songnian Hu, Jun Wang, Gane Ka-Shu Wong, Songgang Li, Bin Liu, Yajun Deng, Li Dai. A Draft Sequence of the Rice Genome (Oryza sativa L. ssp. indica) Science, 2002, retrieved 5 April 2005^
  87. The 3,000 rice genomes project GigaScience, 2014^
  88. Harris A. Lewin, Gene E. Robinson, W. John Kress, William J. Baker, Jonathan Coddington, Keith A. Crandall, Richard Durbin, Scott V. Edwards. Earth BioGenome Project: Sequencing life for the future of life Proceedings of the National Academy of Sciences, 2018^
  89. Shifeng Cheng, Michael Melkonian, Stephen A. Smith, Samuel Brockington, John M. Archibald, Pierre-Marc Delaux, Fay-Wei Li, Barbara Melkonian. 10KP: A phylodiverse genome sequencing plan GigaScience, 2018, retrieved 20 February 2018^
  90. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution Nature, 9 December 2004, retrieved 1 November 2024^
  91. Ruiqiang Li, Wei Fan, Geng Tian, Hongmei Zhu, Lin He, Jing Cai, Quanfei Huang, Qingle Cai. The sequence and de novo assembly of the giant panda genome Nature, 13 December 2009^
  92. Guojie Zhang, Cai Li, Qiye Li, Bo Li, Denis M. Larkin, Chul Lee, Jay F. Storz, Agostinho Antunes. Comparative genomics reveals insights into avian genome evolution and adaptation Science, American Association for the Advancement of Science, 12 December 2014^
  93. Shaohong Feng, Josefin Stiller, Yuan Deng, Joel Armstrong, Qi Fang, Andrew Hart Reeve, Duo Xie, Guangji Chen. Dense sampling of bird diversity increases power of comparative genomics Nature, 11 November 2020^
  94. Xiaoyu Wei, Sulei Fu, Hanbo Li, Yang Liu, Shuai Wang, Weimin Feng, Yunzhi Yang, Xiawei Liu. Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regeneration Science, American Association for the Advancement of Science, 2 September 2022, retrieved 12 November 2024^
  95. Le Zhang, Tianming Lan, Chuyu Lin, Wenyuan Fu, Yaohua Yuan, Kaixiong Lin, Haimeng Li, Sunil Kumar Sahu. Chromosome-scale genomes reveal genomic consequences of inbreeding in the South China tiger: A comparative study with the Amur tiger Molecular Ecology Resources, February 2023^
  96. A. Chen, Y. Sun, Y. Lei, C. Li, S. Liao, J. Meng, Y. Bai, Z. Liu. Single-cell spatial transcriptome reveals cell-type organization in the macaque cortex Cell, Elsevier Inc, 17 August 2023^
  97. Kirsty Needham. China's BGI gets Australian foothold through mass coronavirus test delivery Reuters, 2020-05-14, retrieved 2020-06-03^
  98. Illumina Nears Win In Bid To Block BGI's DNA Product Sales Law360, 2020-05-11, retrieved 2020-06-03^
  99. BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud GenomeWeb, 11 January 2021, retrieved 2021-01-13^
  100. Illumina Owes BGI $333.8 Million Over Gene-Sequencer Patents (2) news.bloomberglaw.com, retrieved 2022-05-17^
  101. Blake Brittain. Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case Reuters, 2022-05-07, retrieved 2022-05-17^
  102. Blake Brittain. BGI Group units, Illumina settle U.S. lawsuits over DNA sequencing Reuters, 2022-07-14, retrieved 2022-10-05^
  103. Jimmy Quinn. Ex-Georgetown Researcher Claims School Has Withheld Support amid Chinese Biotech Firm's Threats National Review, 2024-09-23, retrieved 2024-09-23^
  104. David McCabe, Tripp Mickle. Chinese Companies' New Tactic to Stop Damaging Research: Legal Threats The New York Times, 2025-02-11, retrieved 2025-02-18^
  105. Kirsty Needham. China gene firm providing worldwide COVID tests worked with Chinese military Reuters, 2021-01-30, retrieved 2021-01-30^
  106. Kirsty Needham, Clare Baldwin. Prenatal test developed with Chinese military stores gene data Reuters, 2021-07-07, retrieved 2021-07-07^
  107. Adrianna Zhang. Genetic Data Collection by Chinese Company Poses Global Policy Challenge, Experts Say Voice of America, 2021-07-16, retrieved 2021-07-19^
  108. German privacy body probes German lab's use of BGI prenatal tests Reuters, 2021-07-14, retrieved 2021-07-14^
  109. Britain says China's BGI must register prenatal tests by Sept 1 Reuters, 2021-08-05, retrieved 2021-08-09^
  110. Clare Baldwin, Kirsty Needham. BGI prenatal gene test under scrutiny for Chinese military links Reuters, 2021-09-07, retrieved 2021-09-07^
  111. Joanna Plucinska. Polish gene project moves to drop Chinese tech on data concerns Reuters, 2021-09-22, retrieved 2021-09-27^
  112. Julian E. Barnes. U.S. Warns of Efforts by China to Collect Genetic Data The New York Times, 2021-10-22, retrieved 2021-10-23^
  113. Kirsty Needham, Stine Jacobsen. Monkey-brain study with link to China's military roils top European university Reuters, 2021-11-18, retrieved 2021-11-20^
  114. Comment on Reuters report Institut Biologisk, 2021-12-01, retrieved 2022-08-18^
  115. Kanishka Singh. U.S. widens investment ban to China's BGI Genomics, drone maker DJI Reuters, 2022-10-08, retrieved 2022-10-19^
  116. DOD Releases List of People's Republic of China (PRC) Military Companies in Accordance With Section 1260H of the National Defense Authorization Act for Fiscal Year 2021 U.S. Department of Defense, 2022-10-05, retrieved 2022-10-05^